mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
MLN4924 |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.1 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
Bosutinib |
FIMM |
pan-cancer |
AAC |
0.68 |
0.1 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.1 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |